![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 140.00 | ACUITE BBB | Stable | Reaffirmed | - |
Total Outstanding | 140.00 | - | - |
Total Withdrawn | 0.00 | - | - |
Rating Rationale |
Acuite has reaffirmed its long-term rating of ‘ACUITE BBB’ (read as ACUITE triple B) on the Rs.140.00 crore bank facilities of Tirupati Starch and Chemicals Limited. The outlook is 'Stable'.
Rationale for Rating The rating takes into account the experienced management and long track record of operations of the company. The rating further considers the decline recorded in company’s revenue in FY2024 to Rs. 306.11 Cr from Rs. 364.69 Cr in FY2023. The decline in revenue in FY2024 is on account of capital expenditure being undertaken by the company to add a new product i.e. liquid glucose in the product profile which required an increase in the existing starch capacity due to which the capacity utilisation remained subdued in order to complete the capacity expansion. However, the operating profit margin of the company improved and stood at 6.76% in FY2024 against 5.89% in FY2023. Further, the operating revenue of the company increased in H1FY25 to Rs.189.50 Cr as compared to Rs.136.84 Cr in H1FY24 on account of increase in capacity utilisation. It also takes into consideration the subdued operating profitability margins in H1FY25 which stood at 4.02% as compared to 5.87% in H1FY24, primarily on account of increased material cost. However, on a Q-o-Q basis, the revenue and profitability has improved in Q2FY25 as compared to Q1FY25 levels. Revenue grew to Rs.103.27 Cr. in Q2FY25 as compared to Rs.86.23 Cr. in Q1FY25 and operating profitability grew to 4.87% in Q2FY25 as compared to 3.00% in Q1FY25. Going ahead, the ability of the company to continue growth in its scale of operations and further improvement in the profitability levels remains a key rating monitorable. Acuite believes, that the extent of impact of delay in capex completion on the business and financial risk profile along with overall liquidity position remains a critical rating monitorable. Furthermore, the rating remains constrained on account of moderately intensive working capital nature of operations with GCA days of 117 days in FY 2024 and by susceptibility of its profitability to fluctuations in raw material prices. |
About the Company |
Indore based, Tirupati Starch and Chemicals Limited (TSCL) is engaged in the manufacturing of various products such as maize starch, maize gluten, dextrose monohydrates (edible), poultry feed etc. Tirupati Starch and Chemicals Limited was incorporated in 1985 by Late Mr. Damodar Modi, Mr. Ramdas Goyal and Mr. Prakash Chandra Bafna. |
Unsupported Rating |
Not Applicable |
Analytical Approach |
Acuité has taken a standalone view of business and financial risk profile of TSPL to arrive at the rating |
Key Rating Drivers |
Strengths |
Experienced Management
Tirupati Starch and Chemicals Limited (TSCL) was established in 1985 by late Mr. Damodar Modi, Mr. Ramdas Goyal and Mr. Prakash Chandra Bafna. Mr. Ramdas Goyal holds an overall experience of around four decades in the business of Maize Starch, dextrose and other chemicals. Mr. Prakash Chandra Bafna holds an overall experience of around three decades in manufacturing and trading of chemicals and he also takes care of procurement of raw material and other purchases. The promoters are supported by Mr. Amit Modi and Mr. Yogesh Kumar Agarwal, both of whom hold extensive experience of more than two decades in the business. Extensive experience of the management has helped TSCL establish healthy relationships with customers and suppliers in the industry over the years. Moderate financial risk profile The tangible net worth of the company stood at Rs.74.16 Cr as on March 31, 2024, as against Rs.65.55 crore as on March 31, 2023. The increase in the net worth is due to accretion of profits to reserves and equity infusion of Rs.1.50 Cr by the company in FY24 and consideration of Rs.20.69 Cr USL as quasi-equity. The gearing of the company stood at 1.79 times as on March 31, 2024, as against 1.07 times as on March 31, 2023. The interest coverage ratio stood at 2.07 times as on March 31, 2024, as against 2.59 times as on March 31, 2023. The DSCR stood at 1.20 times as on March 31, 2024, as against1.97 times as on March 31, 2023. The moderation in debt coverage indicators is on account of increased interest cost as the company assumed higher debt during the year to fund working capital operations and ongoing capital expenditure. The capex is being undertaken for addition of liquid glucose in their portfolio. Acuite believes the company’s ability to complete the ongoing capex without further delays and improve its scale of operations and profitability while maintaining adequate liquidity position will be a key rating monitorable. |
Weaknesses |
Moderately Intensive Working Capital Operations |
Rating Sensitivities |
|
Liquidity Position |
Stretched |
The company has a stretched liquidity position. The company generated sufficient net cash accruals against maturing debt obligations in FY24. The net cash accruals stood at Rs.9.81 Cr in FY24 as against maturing debt obligations of Rs. 6.53 crore over the same period. However, the company’s estimated cash accruals are likely to remain modest against repayment obligations, in case of further delay in completion of ongoing capex. The current ratio stood at 1.59 times as on March 31, 2024. |
Outlook: Stable |
Acuité believes that TSCL will maintain a 'Stable' outlook over the medium term on the back of its experienced management and long track record of operations. The outlook may be revised to 'Positive' if TSCL records higher than expected improvement in scale of operations and profitability from Q2FY25 onwards, while maintaining financial risk profile and adequate liquidity position. The outlook may be revised to 'Negative' if TSCL experiences lower than expected revenue growth and improvement in profitability or deterioration in financial risk profile or stretch in its liquidity. |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 306.34 | 364.69 |
PAT | Rs. Cr. | 2.07 | 6.57 |
PAT Margin | (%) | 0.68 | 1.80 |
Total Debt/Tangible Net Worth | Times | 1.79 | 1.07 |
PBDIT/Interest | Times | 2.07 | 2.59 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |